B. Foxman, R. Barlow, D. Arcy, H. Gillespie, B. Sobel et al., Urinary tract infection: self-reported incidence and associated costs, Ann Epidemiol, vol.1012, issue.8, pp.509-524, 2000.

K. Naber, G. Schito, H. Botto, J. Palou, and T. Mazzei, Surveillance Study in Europe and Brazil on Clinical Aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for Empiric Therapy, European Urology, vol.54, issue.5, pp.1164-7531, 2008.
DOI : 10.1016/j.eururo.2008.05.010

T. Le and L. Miller, Empirical Therapy for Uncomplicated Urinary Tract Infections in an Era of Increasing Antimicrobial Resistance: A Decision and Cost Analysis, Clinical Infectious Diseases, vol.33, issue.5, pp.615-636, 2001.
DOI : 10.1086/322603

H. Goossens, M. Ferech, V. Stichele, R. Elseviers, and M. , Outpatient antibiotic use in Europe and association with resistance: a cross-national database study, The Lancet, vol.365, issue.9459, pp.579-87
DOI : 10.1016/S0140-6736(05)70799-6

C. Costelloe, C. Metcalfe, A. Lovering, D. Mant, and A. Hay, Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis Antimicrobial resistance surveillance in Europe Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) Stockholm: ECDC; 2010 Available from, BMJ, vol.340, 2009.

A. Carbonne, I. Arnaud, S. Maugat, N. Marty, C. Dumartin et al., National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. The Journal of antimicrobial chemotherapy, pp.954-963, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00802748

T. Hooton, R. Besser, B. Foxman, T. Fritsche, and L. Nicolle, Acute Uncomplicated Cystitis in an Era of Increasing Antibiotic Resistance: A Proposed Approach to Empirical Therapy, Clinical Infectious Diseases, vol.39, issue.1, pp.75-80, 2004.
DOI : 10.1086/422145

H. Arslan, O. Azap, O. Ergonul, and F. Timurkaynak, Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. The Journal of antimicrobial chemotherapy, pp.914-922, 2005.

R. Colodner, I. Kometiani, B. Chazan, R. Raz, J. Johnson et al., Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrobial agents and chemotherapy, Feb, vol.3652, issue.13, pp.41-5846, 2008.

A. Sundsfjord, I. Sandven, C. Brunborg, J. Pachanoine, M. Gruson et al., Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country):e69581. PubMed PMID: 23936052. Pubmed Central PMCID: 3720588 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. The Journal of antimicrobial chemotherapy Virtual surveillance of communicable diseases: a 20-year experience in France, PubMed PMID: 18086847. Pubmed Central PMCID: 2258492, pp.562-8413, 2006.

G. Kahlmeter, An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. The Journal of antimicrobial chemotherapy, pp.69-76, 2003.

P. Pubmed, G. Marcade, L. Raskine, I. Malissin, and B. Megarbane, Enterobacteriaceae producing extended spectrum beta-lactamase: epidemiology, risk factors, and prevention], Epub Rev Med Interne, vol.34, issue.11, pp.12493789687-93, 2002.

P. U. Pubmed, Enterobacteries productrices de beta-lactamases a spectre elargi : epidemiologie, facteurs de risque et mesures de prevention. 17. Société française de microbiologie. Recommandations du comité de l'antibiogramme de la société française de microbiologie 2013 Available from, p.23182290

V. Jarlier, M. Nicolas, G. Fournier, and A. Philippon, Extended Broad-Spectrum ??-Lactamases Conferring Transferable Resistance to Newer ??-Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns, Clinical Infectious Diseases, vol.10, issue.4, pp.867-78, 1988.
DOI : 10.1093/clinids/10.4.867

D. Champs, C. Chanal, C. Sirot, D. Baraduc, R. Romaszko et al., Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. The Journal of antimicrobial chemotherapy, pp.634-643, 2004.

C. Eckert, V. Gautier, M. Saladin-allard, N. Hidri, C. Verdet et al., Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae Antimicrobial agents and chemotherapy Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, pp.1249-55268, 2004.

S. Lemeshow, L. Letenneur, J. Dartigues, S. Lafont, J. Orgogozo et al., Illustration of Analysis Taking into Account Complex Survey Considerations: The Association between Wine Consumption and Dementia in the PAQUID Study, American Journal of Epidemiology, vol.148, issue.3, pp.298-306, 1998.
DOI : 10.1093/oxfordjournals.aje.a009639

T. Lumley, Analysis of complex survey samples):1-19. 25. ONERBA. Annual report, Journal of Statistical Software, vol.921, issue.1, 2004.

M. Etienne, E. Lefebvre, N. Frebourg, H. Hamel, M. Pestel-caron et al., Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series, Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. International journal of antimicrobial agents, p.137, 2012.
DOI : 10.1093/jac/dks222

N. Adriaenssens, S. Coenen, A. Versporten, A. Muller, G. Minalu et al., PubMed PMID: 22055529. 28 European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe The Journal of antimicrobial chemotherapy, pp.45-51, 1997.

S. Hillier, Z. Roberts, F. Dunstan, C. Butler, A. Howard et al., Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. The Journal of antimicrobial chemotherapy, 2007.

W. Starre, C. Van-nieuwkoop, S. Paltansing, J. Van-'t-wout, G. Groeneveld et al., PubMed PMID: 17540675. Epub Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection, pp.92-101, 2007.

S. Kline and S. Duval, Risk factors for community-and health facility-acquired extended-spectrum beta-lactamase-producing bacterial infections in patients at the University of Minnesota Medical Center, Fairview. American journal of infection control, pp.650-6849, 2011.

S. Aguilar-duran, J. Horcajada, L. Sorli, M. Montero, M. Salvado et al., Community-onset healthcarerelated urinary tract infections: comparison with community and hospital-acquired urinary tract infections. The Journal of infection PubMed PMID: 22285591. 33. Overdevest I Extended-spectrum betalactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerging infectious diseases Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study, PloS one, vol.64177, issue.571, pp.478-831216, 2011.